You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 11, 2025

List of Excipients in API metformin hydrochloride extended-release tablets


✉ Email this page to a colleague

« Back to Dashboard


Excipients in ANDA-approved (generic) drugs containing metformin hydrochloride extended-release tablets

Company Ingredient NDC Excipient
AiPing Pharmaceutical Inc metformin hydrochloride extended-release tablets 11788-037 ACETONE
AiPing Pharmaceutical Inc metformin hydrochloride extended-release tablets 11788-037 CELLULOSE ACETATE
AiPing Pharmaceutical Inc metformin hydrochloride extended-release tablets 11788-037 FERROSOFERRIC OXIDE
AiPing Pharmaceutical Inc metformin hydrochloride extended-release tablets 11788-037 HYPROMELLOSES
AiPing Pharmaceutical Inc metformin hydrochloride extended-release tablets 11788-037 MAGNESIUM STEARATE
AiPing Pharmaceutical Inc metformin hydrochloride extended-release tablets 11788-037 POLYETHYLENE GLYCOL 400
>Company >Ingredient >NDC >Excipient

Subscribe to access the full database, or Get Started Free

Detailed excipient profiles for metformin hydrochloride extended-release tablets

Excipient focus: ACETONE

Excipient focus: AMMONIO METHACRYLATE COPOLYMER TYPE A

Excipient focus: CELLULOSE ACETATE

Excipient focus: COPOVIDONE K25-31

Excipient focus: CROSPOVIDONE

Excipient focus: FERROSOFERRIC OXIDE

Excipient focus: HYPROMELLOSE

Excipient focus: HYPROMELLOSES

Excipient focus: MAGNESIUM STEARATE

metformin hydrochloride extended-release tablets drug variants containing MAGNESIUM STEARATE

Company Ingredient NDC
AiPing Pharmaceutical Inc metformin hydrochloride extended-release tablets 11788-037
ScieGen Pharmaceuticals Inc metformin hydrochloride extended-release tablets 50228-445
ScieGen Pharmaceuticals Inc metformin hydrochloride extended-release tablets 50228-503
Qingdao BAHEAL Pharmaceutical Co Ltd metformin hydrochloride extended-release tablets 70247-018
>Company >Ingredient >NDC

Subscribe to access the full database, or Get Started Free

Excipient focus: POLYETHYLENE GLYCOL

Excipient focus: POLYETHYLENE GLYCOL 400

Excipient focus: POLYETHYLENE GLYCOL 8000

Excipient focus: POLYSORBATE 80

Excipient focus: POVIDONE

Excipient focus: SHELLAC

Excipient focus: SILICON DIOXIDE

Excipient focus: SODIUM LAURYL SULFATE

Excipient focus: STARCH, CORN

Excipient focus: TALC

Excipient focus: TITANIUM DIOXIDE

metformin hydrochloride extended-release tablets drug variants containing TITANIUM DIOXIDE

Company Ingredient NDC
AiPing Pharmaceutical Inc metformin hydrochloride extended-release tablets 11788-037
ScieGen Pharmaceuticals Inc metformin hydrochloride extended-release tablets 50228-445
ScieGen Pharmaceuticals Inc metformin hydrochloride extended-release tablets 50228-503
Qingdao BAHEAL Pharmaceutical Co Ltd metformin hydrochloride extended-release tablets 70247-018
>Company >Ingredient >NDC

Subscribe to access the full database, or Get Started Free

Excipient focus: TRIACETIN

Excipient focus: TRIETHYL CITRATE

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

 
© Copyright 2002-2025 thinkBiotech LLC
ISSN: 2162-2639
Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2025 - 2026
 NCE-1 Patent Challenge Dates 2025 - 2026
Preferred Citation:

Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2025, www.DrugPatentWatch.com.
   See Primary Research Papers Citing DrugPatentWatch

Links